These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9753246)

  • 1. Molecular analysis of suppression of interleukin-8 production by rebamipide in Helicobacter pylori-stimulated gastric cancer cell lines.
    Aihara M; Azuma A; Takizawa H; Tsuchimoto D; Funakoshi Y; Shindo Y; Ohmoto Y; Imagawa K; Kikuchi M; Mukaida N; Matsushima K
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):174S-180S. PubMed ID: 9753246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebamipide inhibits ceramide-induced interleukin-8 production in Kato III human gastric cancer cells.
    Masamune A; Yoshida M; Sakai Y; Shimosegawa T
    J Pharmacol Exp Ther; 2001 Aug; 298(2):485-92. PubMed ID: 11454909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of rebamipide on Helicobacter pylori extract-mediated changes of gene expression in gastric epithelial cells.
    Yoshida N; Ishikawa T; Ichiishi E; Yoshida Y; Hanashiro K; Kuchide M; Uchiyama K; Kokura S; Ichikawa H; Naito Y; Yamamura Y; Okanoue T; Yoshikawa T
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():63-75. PubMed ID: 12925142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of rebamipide on the neutrophil adherence stimulated by conditioned media from Helicobacter pylori-infected gastric epithelial cells.
    Kim CD; Kim HH; Hong KW
    J Pharmacol Exp Ther; 1999 Jan; 288(1):133-8. PubMed ID: 9862763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45.
    Aihara M; Tsuchimoto D; Takizawa H; Azuma A; Wakebe H; Ohmoto Y; Imagawa K; Kikuchi M; Mukaida N; Matsushima K
    Infect Immun; 1997 Aug; 65(8):3218-24. PubMed ID: 9234778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of lipid peroxidation, NF-kappaB activation and IL-8 production by rebamipide in Helicobacter pylori-stimulated gastric epithelial cells.
    Kim H; Seo JY; Kim KH
    Dig Dis Sci; 2000 Mar; 45(3):621-8. PubMed ID: 10749342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NFκB and suppresses invasion of gastric cancer cells.
    Kang DW; Hwang WC; Park MH; Ko GH; Ha WS; Kim KS; Lee YC; Choi KY; Min DS
    Oncogene; 2013 Jul; 32(30):3531-42. PubMed ID: 22890316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of Helicobacter pylori-induced interleukin-8 production in gastric cancer cell lines by an anti-ulcer drug, geranylgeranylacetone.
    Yoshimura N; Suzuki Y; Saito Y
    J Gastroenterol Hepatol; 2002 Nov; 17(11):1153-60. PubMed ID: 12453273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rebamipide attenuates Helicobacter pylori CagA-induced self-renewal capacity via modulation of β-catenin signaling axis in gastric cancer-initiating cells.
    Kang DW; Noh YN; Hwang WC; Choi KY; Min do S
    Biochem Pharmacol; 2016 Aug; 113():36-44. PubMed ID: 27265143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of rebamipide on production of several cytokines by human peripheral blood mononuclear cells.
    Aihara M; Imagawa K; Funakoshi Y; Ohmoto Y; Kikuchi M
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):160S-166S. PubMed ID: 9753244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of long-term administration of rebamipide on Helicobacter pylori infection in mice.
    Hahm KB; Kim DH; Lee KM; Lee JS; Surh YJ; Kim YB; Yoo BM; Kim JH; Joo HJ; Cho YK; Nam KT; Cho SW
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():24-38. PubMed ID: 12925138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells.
    Hayashi S; Sugiyama T; Amano K; Isogai H; Isogai E; Aihara M; Kikuchi M; Asaka M; Yokota K; Oguma K; Fujii N; Hirai Y
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1895-9. PubMed ID: 9687380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of rebamipide on the expression of proinflammatory mediators and apoptosis in human neutrophils by Helicobacter pylori water-soluble surface proteins.
    Kim JS; Kim JM; Jung HC; Song IS
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():45-54. PubMed ID: 12925140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants.
    Suzuki M; Miura S; Mori M; Kai A; Suzuki H; Fukumura D; Suematsu M; Tsuchiya M
    Gut; 1994 Oct; 35(10):1375-8. PubMed ID: 7959190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonopsonic activation of neutrophils by Helicobacter pylori is inhibited by rebamipide.
    Danielsson D; Jurstrand M
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):167S-173S. PubMed ID: 9753245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effect of rebamipide and ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells.
    Hayashi S; Sugiyama T; Yokota K; Isogai H; Isogai E; Shimomura H; Oguma K; Asaka M; Hirai Y
    Microbiol Immunol; 2000; 44(7):557-62. PubMed ID: 10981828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rebamipide protects against activation of neutrophils by Helicobacter pylori.
    Yoshida N; Yoshikawa T; Iinuma S; Arai M; Takenaka S; Sakamoto K; Miyajima T; Nakamura Y; Yagi N; Naito Y; Mukai F; Kondo M
    Dig Dis Sci; 1996 Jun; 41(6):1139-44. PubMed ID: 8654144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rebamipide induces dendritic cell recruitment to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-exposed rat gastric mucosa based on IL-1β upregulation.
    Yamamichi N; Oka M; Inada K; Konno-Shimizu M; Kageyama-Yahara N; Tamai H; Kato J; Fujishiro M; Kodashima S; Niimi K; Ono S; Tsutsumi Y; Ichinose M; Koike K
    Biochem Biophys Res Commun; 2012 Jul; 424(1):124-9. PubMed ID: 22732404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing.
    Arakawa T; Kobayashi K; Yoshikawa T; Tarnawski A
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):5S-13S. PubMed ID: 9753220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of rebamipide on H. pylori-associated gastric mucosal injury in Mongolian gerbils.
    Suzuki H; Mori M; Kai A; Suzuki M; Suematsu M; Miura S; Ishii H
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):181S-187S. PubMed ID: 9753247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.